Amerikanische Gesellschaft für Hirudotherapie

Drug Administration of Vietnam / Department of Medical Equipment and Health Works

DAV / MOH-MD · Vietnam · asia pacific

Regulatory jurisdiction profileJurisdictional reference
Traditional medicinenational regulator

Vietnam's Ministry of Health medical-device and pharmaceutical authorities — leech-specific regulation has not been independently verified by ASH and may fall under traditional-medicine carve-outs.

Regulatory Profile

Agency type
national regulator
Region
asia pacific
Country
Vietnam
Leech status
traditional medicine
Last ASH review
2026-05-25

Relevant Regulation Codes

  • Pharmacy Law of Vietnam (Law No. 105/2016/QH13)
  • Decree on management of medical devices (Vietnamese national medical-device framework)

Prescriber Requirements

  • Vietnamese-licensed physician (bác sĩ) prescription required
  • Traditional medicine practitioners (y học cổ truyền) registered under the Ministry of Health may have separate scope; specific hirudotherapy authorisation not independently verified by ASH

Supply Chain & GMP

Vietnamese national medical-device registration via the Ministry of Health Department of Medical Equipment and Health Works; Vietnamese-language labelling.

Import/Export Rules

Ministry of Health import licence; Department of Animal Health veterinary clearance for live invertebrates; standard CITES Appendix II paperwork for Hirudo medicinalis.

Reimbursement Context

Vietnam Social Security health insurance (BHYT) coverage for traditional medicine modalities including hirudotherapy not independently verified by ASH.

ASH Editorial Notes

Vietnam has a strong traditional medicine tradition (y học cổ truyền) institutionalised in parallel with biomedicine via the Vietnam National Hospital of Traditional Medicine. Specific leech regulatory pathway has not been independently verified by ASH; the status "traditional-medicine" reflects the likely framework but should be confirmed with Vietnamese counsel.

Related Jurisdictions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.